Colistin dosing and nephrotoxicity in a large community teaching hospital
- PMID: 20660694
- PMCID: PMC2944569
- DOI: 10.1128/AAC.01707-09
Colistin dosing and nephrotoxicity in a large community teaching hospital
Abstract
Thirty adult patients who received intravenous colistin (5.1 ± 2.4 mg/kg/day) were reviewed to evaluate dosing with respect to nephrotoxicity, which occurred in 10 (33%) patients within the first 5 days of treatment. Excessive colistin dosing was frequent (47%), often (71%) resulted from the use of actual body weight in obese patients, and was associated with higher rates of nephrotoxicity (80% versus 30%, P = 0.019).
References
-
- Cockcroft, D. W., and M. H. Gault. 1976. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41. - PubMed
-
- Devine, B. 1974. Gentamicin therapy. Drug Intell. Clin. Pharm. 8:650-655.
-
- Evans, M. E., D. J. Feola, and R. P. Rapp. 1999. Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria. Ann. Pharmacother. 33:960-967. - PubMed
-
- Falagas, M. E., K. N. Fragoulis, S. K. Kasiakou, G. J. Sermaidis, and A. Michalopoulos. 2005. Nephrotoxicity of intravenous colistin: a prospective evaluation. Int. J. Antimicrob. Agents 26:504-507. - PubMed
-
- Falagas, M. E., S. K. Kasiakou, D. P. Kofteridis, G. Roditakis, and G. Samonis. 2006. Effectiveness and nephrotoxicity of intravenous colistin for treatment of patients with infections due to polymyxin-only-susceptible (POS) gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 25:596-599. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical